CNC
Centene Corporation NYSE Listed Dec 13, 2001$54.95
After hrs
$56.29
+0.59%
Mkt Cap $27.1B
52w Low $25.08
76.5% of range
52w High $64.15
50d MA $39.95
200d MA $37.13
P/E (TTM)
-3.9x
EV/EBITDA
-4.1x
P/B
1.3x
Debt/Equity
0.9x
ROE
-30.1%
P/FCF
4.7x
RSI (14)
—
ATR (14)
—
Beta
0.59
50d MA
$39.95
200d MA
$37.13
Avg Volume
6.7M
Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray, home-based primary care, transportation assistance, vision care, dental care, telehealth, immunization, specialty pharmacy, therapy, social work, nurse advisory, and care coordination services, as well as prescriptions and limited over-the-counter drugs, medical equipment, and behavioral health and abuse services. This segment also offers various individual, small group, and large group commercial healthcare products to employers and directly to members. The company's Specialty Services segment provides pharmacy benefits management services; nurse advice line and after-hours support services; vision and dental services, as well as staffing services to correctional systems and other government agencies; and services to Military Health System eligible beneficiaries. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.
Centene Plaza · Saint Louis, MO 63105 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 28, 2026 | TNS | 2.23 | 3.37 | +51.1% | 49.57 | +2.0% | +8.9% | +8.3% | +7.6% | +8.0% | +6.9% | — |
| Feb 6, 2026 | TNS | -1.22 | -1.19 | +2.5% | 38.46 | -0.1% | -1.1% | +3.0% | +5.1% | +1.9% | +5.5% | — |
| Oct 29, 2025 | TNS | -0.14 | 0.50 | +445.4% | 37.34 | -1.6% | -6.2% | -5.3% | -7.6% | -3.3% | -1.3% | — |
| Jul 25, 2025 | TNS | 0.11 | -0.16 | -243.4% | 28.39 | -0.8% | -5.4% | -10.1% | -9.2% | -8.2% | -8.7% | — |
| Apr 25, 2025 | TNS | 2.52 | 2.90 | +15.1% | 57.69 | +0.5% | +3.1% | +2.7% | +3.7% | +3.0% | +4.3% | — |
| Feb 4, 2025 | TNS | 0.44 | 0.80 | +81.8% | 61.29 | -0.6% | -0.9% | -4.3% | -3.8% | -3.9% | -6.4% | — |
| Oct 25, 2024 | TNS | 1.33 | 1.62 | +21.8% | 64.22 | -0.9% | -4.0% | -5.6% | -3.8% | -3.1% | -1.1% | — |
| Jul 26, 2024 | TNS | 2.07 | 2.42 | +16.9% | 73.10 | +0.4% | +0.5% | +5.5% | +5.2% | +6.6% | +6.8% | — |
| Apr 26, 2024 | TNS | 2.08 | 2.26 | +8.7% | 74.00 | +0.5% | -0.2% | -1.3% | -2.4% | +0.4% | +1.1% | — |
| Feb 6, 2024 | TNS | 0.43 | 0.45 | +4.7% | 74.92 | +0.1% | +0.0% | +2.1% | +3.2% | +4.0% | +2.4% | — |
| Oct 24, 2023 | TNS | 1.58 | 2.00 | +26.6% | 69.69 | -0.1% | -1.4% | -2.3% | -3.2% | -2.5% | -1.0% | — |
| Jul 28, 2023 | TNS | 2.03 | 2.10 | +3.4% | 66.18 | +0.1% | +2.9% | +2.8% | +1.8% | -0.2% | -0.6% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29 | Barclays | Maintains | Overweight → Overweight | — | $49.57 | $50.58 | +2.0% | +8.9% | +8.3% | +7.6% | +8.0% | +6.9% |
| Apr 29 | Oppenheimer | Maintains | Outperform → Outperform | — | $49.57 | $50.58 | +2.0% | +8.9% | +8.3% | +7.6% | +8.0% | +6.9% |
| Apr 29 | Cantor Fitzgerald | Upgrade | Neutral → Overweight | $60 | $49.57 | $50.58 | +2.0% | +8.9% | +8.3% | +7.6% | +8.0% | +6.9% |
| Apr 29 | UBS | Maintains | Neutral → Neutral | — | $49.57 | $50.58 | +2.0% | +8.9% | +8.3% | +7.6% | +8.0% | +6.9% |
| Apr 29 | Truist | Maintains | Buy → Buy | — | $49.57 | $50.58 | +2.0% | +8.9% | +8.3% | +7.6% | +8.0% | +6.9% |
| Apr 29 | BofA Securities | Upgrade | Underperform → Buy | $60 | $49.57 | $50.58 | +2.0% | +8.9% | +8.3% | +7.6% | +8.0% | +6.9% |
| Apr 20 | Jefferies | Maintains | Hold → Hold | — | $38.17 | $38.41 | +0.6% | +0.4% | +2.5% | +2.0% | +7.7% | +9.6% |
| Mar 19 | JP Morgan | Maintains | Neutral → Neutral | — | $36.16 | $36.14 | -0.1% | -1.6% | -4.9% | -9.3% | -8.8% | -9.5% |
| Mar 11 | Mizuho | Maintains | Neutral → Neutral | — | $36.40 | $36.31 | -0.2% | -1.5% | -5.0% | -5.4% | -4.5% | -4.0% |
| Mar 4 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $43.82 | $44.16 | +0.8% | +2.7% | -1.3% | -0.4% | -1.1% | -16.9% |
| Feb 18 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $41.23 | $41.50 | +0.7% | +4.5% | +5.9% | +4.9% | +5.1% | +2.8% |
| Feb 9 | Cantor Fitzgerald | Maintains | Neutral → Neutral | — | $38.46 | $38.42 | -0.1% | -1.1% | +3.0% | +5.1% | +1.9% | +5.5% |
| Jan 7 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $45.74 | $46.81 | +2.3% | +0.1% | +2.6% | +1.9% | +1.4% | +0.0% |
| Jan 5 | Barclays | Upgrade | Equal Weight → Overweight | — | $41.78 | $42.99 | +2.9% | +6.9% | +9.5% | +9.6% | +12.3% | +11.6% |
| Nov 21 | Bernstein | Maintains | Outperform → Outperform | — | $34.83 | $35.25 | +1.2% | +4.8% | +9.6% | +13.9% | +13.3% | +12.9% |
| Nov 12 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $35.36 | $35.23 | -0.4% | +2.4% | +2.1% | +2.9% | +4.9% | +4.4% |
| Nov 4 | Barclays | Maintains | Equal Weight → Equal Weight | — | $34.50 | $34.24 | -0.8% | +4.7% | +6.8% | +7.5% | +8.9% | -0.7% |
| Nov 4 | JP Morgan | Maintains | Neutral → Neutral | — | $34.50 | $34.24 | -0.8% | +4.7% | +6.8% | +7.5% | +8.9% | -0.7% |
| Oct 31 | TD Cowen | Maintains | Hold → Hold | — | $35.02 | $34.60 | -1.2% | +1.0% | -1.5% | +3.1% | +5.2% | +5.9% |
| Oct 31 | Goldman Sachs | Maintains | Sell → Sell | — | $35.02 | $34.60 | -1.2% | +1.0% | -1.5% | +3.1% | +5.2% | +5.9% |
| Oct 30 | Truist | Maintains | Buy → Buy | — | $37.34 | $36.76 | -1.6% | -6.2% | -5.3% | -7.6% | -3.3% | -1.3% |
| Oct 30 | UBS | Maintains | Neutral → Neutral | — | $37.34 | $36.76 | -1.6% | -6.2% | -5.3% | -7.6% | -3.3% | -1.3% |
| Oct 30 | Cantor Fitzgerald | Maintains | Neutral → Neutral | — | $37.34 | $36.76 | -1.6% | -6.2% | -5.3% | -7.6% | -3.3% | -1.3% |
| Oct 14 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $36.36 | $35.83 | -1.5% | +0.2% | -1.6% | -2.0% | -3.0% | -2.1% |
| Oct 9 | Mizuho | Maintains | Neutral → Neutral | — | $38.45 | $38.76 | +0.8% | -1.6% | -7.0% | -5.4% | -5.2% | -6.9% |
| Oct 7 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $37.64 | $38.30 | +1.8% | +2.1% | +2.2% | +0.5% | -5.0% | -3.4% |
| Sep 12 | Truist | Maintains | Buy → Buy | — | $34.08 | $33.92 | -0.5% | -2.4% | -4.2% | -6.7% | -6.0% | -5.6% |
| Sep 12 | Barclays | Maintains | Equal Weight → Equal Weight | — | $34.08 | $33.92 | -0.5% | -2.4% | -4.2% | -6.7% | -6.0% | -5.6% |
| Sep 5 | Bernstein | Maintains | Outperform → Outperform | — | $28.65 | $28.59 | -0.2% | +1.2% | +0.7% | +8.4% | +9.1% | +19.0% |
| Sep 4 | Barclays | Maintains | Equal Weight → Equal Weight | — | $30.06 | $29.25 | -2.7% | -4.7% | -3.6% | -4.1% | +3.3% | +4.0% |
| Aug 26 | Cantor Fitzgerald | Maintains | Neutral → Neutral | — | $29.08 | $29.01 | -0.2% | -1.4% | -0.8% | -2.4% | -0.1% | +1.9% |
| Aug 4 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $25.91 | $25.96 | +0.2% | +1.2% | -0.1% | -2.7% | -2.5% | -1.2% |
| Jul 29 | JP Morgan | Maintains | Neutral → Neutral | — | $26.86 | $26.32 | -2.0% | -5.0% | -4.0% | -2.9% | -3.5% | -2.4% |
| Jul 28 | Truist | Maintains | Buy → Buy | — | $28.39 | $28.16 | -0.8% | -5.4% | -10.1% | -9.2% | -8.2% | -8.7% |
| Jul 28 | UBS | Maintains | Neutral → Neutral | — | $28.39 | $28.16 | -0.8% | -5.4% | -10.1% | -9.2% | -8.2% | -8.7% |
| Jul 28 | Cantor Fitzgerald | Downgrade | Overweight → Neutral | — | $28.39 | $28.16 | -0.8% | -5.4% | -10.1% | -9.2% | -8.2% | -8.7% |
| Jul 28 | Oppenheimer | Maintains | Outperform → Outperform | — | $28.39 | $28.16 | -0.8% | -5.4% | -10.1% | -9.2% | -8.2% | -8.7% |
| Jul 25 | Baird | Maintains | Neutral → Neutral | — | $26.76 | $27.13 | +1.4% | +6.1% | +0.4% | -4.6% | -3.6% | -2.6% |
| Jul 23 | Wells Fargo | Downgrade | Overweight → Equal Weight | — | $27.89 | $28.06 | +0.6% | +5.5% | -4.1% | +1.8% | -3.7% | -8.5% |
| Jul 21 | TD Cowen | Downgrade | Buy → Hold | — | $27.95 | $28.08 | +0.5% | -1.9% | -0.2% | +5.3% | -4.3% | +1.6% |
| Jul 16 | BofA Securities | Downgrade | Neutral → Underperform | — | $30.00 | $29.83 | -0.6% | +1.4% | -2.9% | -6.8% | -8.6% | -7.0% |
| Jul 16 | Truist | Maintains | Buy → Buy | — | $30.00 | $29.83 | -0.6% | +1.4% | -2.9% | -6.8% | -8.6% | -7.0% |
| Jul 15 | Oppenheimer | Maintains | Outperform → Outperform | — | $30.64 | $30.47 | -0.6% | -2.1% | -0.8% | -4.9% | -8.8% | -10.5% |
| Jul 11 | Mizuho | Maintains | Neutral → Neutral | — | $32.52 | $32.25 | -0.8% | -3.3% | -5.8% | -7.7% | -6.5% | -10.4% |
| Jul 10 | Morgan Stanley | Downgrade | Overweight → Equal Weight | — | $33.09 | $32.33 | -2.3% | -1.7% | -5.0% | -7.4% | -9.3% | -8.1% |
| Jul 2 | Barclays | Maintains | Equal Weight → Equal Weight | — | $56.65 | $37.34 | -34.1% | -40.4% | -41.2% | -41.7% | -42.5% | -41.6% |
| Jul 2 | UBS | Downgrade | Buy → Neutral | — | $56.65 | $37.34 | -34.1% | -40.4% | -41.2% | -41.7% | -42.5% | -41.6% |
| Jul 2 | JP Morgan | Downgrade | Overweight → Neutral | — | $56.65 | $37.34 | -34.1% | -40.4% | -41.2% | -41.7% | -42.5% | -41.6% |
| Jul 2 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $56.65 | $37.34 | -34.1% | -40.4% | -41.2% | -41.7% | -42.5% | -41.6% |
| Jul 2 | BofA Securities | Maintains | Neutral → Neutral | — | $56.65 | $37.34 | -34.1% | -40.4% | -41.2% | -41.7% | -42.5% | -41.6% |
No insider trades available.
8-K
Centene Corporation -- 8-K Filing
Centene's Medicaid health benefit ratio of 93.1% demonstrates improved cost management and operational efficiency, indicating stronger profitability in its core business segment.
Apr 28
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
CNC's promotion of a long-tenured finance executive to lead innovation signals management confidence in operational efficiency and digital transformation, potentially improving margins and competitive positioning for investors.
Mar 24
8-K · 8.01
!! High
Unknown — 8-K 8.01: Material Event / Announcement
The company is redeeming $1 billion of 2027 notes early, reducing debt obligations and likely lowering future interest expenses, signaling financial strength and improved capital management.
Mar 10
8-K · 7.01
! Medium
Centene Corporation -- 8-K 7.01: Regulation FD Disclosure
Centene reaffirms its 2026 GAAP EPS guidance of greater than $1.98 and adjusted EPS guidance exceeding $3.00, maintaining previous projections.
Feb 23
8-K
Centene Corporation -- 8-K Filing
Centene Corporation provided 2026 guidance through a presentation filed as an 8-K, offering investors forward-looking insights into the company's anticipated financial performance.
Feb 6
Data updated apr 25, 2026 2:08am
· Source: massive.com